Global Vascular Disease Devices Market’s Growth to Propel with Rising Cases of Heart Disorders Worldwide

Although a major part of the world and our lives have been greatly impacted since the outbreak of the coronavirus pandemic, it is promising to know that novel technologies with great potential have dramatically enhanced, especially technologies related to vascular diseases. Vascular diseases devices hold the potential to truly transform the way doctors can avert, analyse, and treat vascular disorders outside of the heart. Vascular disease device makers are developing innovative tools and programs to detect chronic vascular illnesses and perilous diabetic ulcers more keenly to treat the most serious artery blockages in a minimally invasive method, and enhance rehab compliance through novel at-home programs.

The medical industry is eagerly looking forward to bring about huge transformations in existing vascular disease devices, as the number of patient of cardiovascular diseases (CVDs) and related heart disorders is surging at a rapid pace across the globe. CVDs are the foremost reason for death worldwide. Round 17.9 million people expired due to CVDs in 2019, representing 32% of the overall global demises.

Currently, the global vascular disease devices market is perceiving a gigantic growth mostly due to growing number of people falling prey to atherosclerosis disorder, a type of disease that is instigated owing to blockages in arteries owing to build up of fats, cholesterol, and other substances on the walls of arteries.

Latest Trends in the Vascular Disease Devices Market

As per a report by Research Dive, the global vascular disease devices market is expected to grow from $13,308.2 million in 2020 to $22,610.3 million by 2028. Asia-Pacific region is the foremost player in the vascular disease devices market and is expected to grow speedily by garnering a revenue of $5,200.4 million by 2028.

Market players are considerably investing in research and development to cater the mounting demand for vascular disease devices. Some of the leading players of the vascular disease devices market are Dickinson and Company, Abbott Laboratories, Becton, B. Braun Melsungen Ag, Venus Medtech, Boston Scientific Corporation, Medtronic, Terumo Corporation, Ivascular, Merit Medical, Cordis, and others. These players are focused on developing strategies such as mergers and acquisitions, partnerships, novel developments, and collaborations to achieve a prominent position in the global market.

For instance,

• In June 2021, the World Health Organization, a dedicated agency of the United Nations accountable for international public health, launched a list of priority medical devices for the management of cardiovascular ailments and diabetes.
• In November 2021, Otsuka Medical Devices Co., Ltd., a medical device manufacturing company and a completely owned subsidiary of Otsuka Holdings Co., Ltd., introduced the BioMimics 3D Vascular Stent System for patients with peripheral vascular disorders in Japan.
• In September 2021, PocDoc, a digital health platform and personal diagnostics supplier, launched the world’s first smartphone-based test for cardiovascular disorders.

COVID-19 Impact on the Vascular Disease Devices Market

The unexpected rise of the COVID-19 pandemic in 2020 has adversely impacted the global vascular disease devices market. This is mainly owing to the result of the worldwide complete lockdown, and major disruptions in the healthcare sector due to the rising number of COVID-19 patients. Moreover, as several manufacturing industries were ceased amidst the pandemic, the production of the vascular disease devices was severely impacted.

Most of the surgeries got postponed because of strict government regulations regarding performing only critical surgical treatments to avoid spread of COVID-19 infection. All these factors hampered the growth global vascular disease devices market during the pandemic period. However, as the world is recovering with the relaxation of pandemic, the vascular disease devices market is expected to observe notable rise, in the upcoming years, with the growing demand for vascular disease devices owing to rising heart related disorders worldwide.